Abstract Background: Understanding the role of environmental and molecular influences on the nature and rate of K-ras mutations in colorectal neoplasms is crucial. COX-2 polymorphisms À765G > C may play a role in carcinogenic processes in combination with specific life-style conditions or dependent on the racial composition of a particular population. If mutational events play an important role in colorectal carcinogenesis sequence, one can hypothesize that modification of these events by life-style or other factors would be a useful prevention strategy. Aim of work: To explore the association between K-ras mutation and potential variables known or suspected to be related to the risk of colorectal cancer (CRC) as well as determining the possible modulating effect of the COX-2 polymorphism, À765G > C. 
Introduction
Colorectal cancer (CRC) is a major health problem in industrialized countries [1] . It is the second most commonly diagnosed cancer in the USA [2] . It has been postulated that approximately 80% of the observed differences in incidence rates between countries can be attributed to dietary factors [3] .
In Egypt, colorectal carcinoma is one of the most common malignant neoplasms and the third leading cause of death. It represents about 6% of cancers in Egypt (after bladder, breast carcinoma and lymphoma) with high male predominance 3:1 and more than 1/3 under age 45 years. It is rectal in 51% of the cases. Associated bilharzial colitis is present in 12% of the cases and associated polyps are found in 5%. About 5% of the cases occur as a hereditary non-polyposis colorectal cancer (HNPCC) [4] .
In 2002, a large body of evidence indicated that some dietary and genetic factors were likely to have a major influence on the risk of colon cancer. Among the dietary factors is the high consumption of red meat, tea, coffee and low consumption of green leafy vegetables [5] .
As regards genetic factors, progresses made in the field of molecular biology have shed light on two important genes implicated in colorectal carcinoma namely cyclooxygenases (COX-2) and Kirsten-Ras (K-ras) [6] .
Kirsten-Ras gene which is thought to be critical in the development of colorectal cancer is present on chromosome 12, and it encodes for p21 Ras [7] . Activating mutations of K-ras occurring early in colorectal tumor genesis are thought to abolish GTPase activity and render the protein resistant to inactivation by regulatory GTPase activating proteins, locking the ras protein in the active GTP bound state leading to increased and unregulated cellular proliferation and malignant transformation [8] .
Despite the high frequency of K-ras mutations in colorectal neoplasms, data on their etiology are sparse [9] . In addition, different authors discovered that colon cancers in patients from different geographic areas are different because different genes are being mutated or abnormally regulated [10, 11] .
Undoubtedly, understanding the influential that may affect the rate of these mutations in colorectal neoplasm is crucial. One can hypothesize that modification of these events by lifestyle or other factors would be a useful prevention strategy.
Many risk factors are accused in the causation of K-ras mutations. Heredity may play a role, however, most cases show history of exposure to environmental risk factors, including dietary factors especially red meat consumption, tea and coffee consumption, smoking, alcoholism and chronic folate deficiency [12] .
COX-2 plays major roles in the inflammatory response [13] . It is well established that patients with inflammatory bowel disease are at increased risk of developing colorectal cancer (CRC) [14] . A common promoter variant, À765G > C (rs20417), a G to C transversion resulting in significantly lower promoter activity, and reduced levels of C-reactive protein (CRP) which is a systemic marker of inflammation [15] . It has been reported that this polymorphism modifies the risk of colorectal cancer [16] . Cyclooxygenase-2 expression in colorectal adenoma cells is strongly correlated with K-ras gene mutation, suggesting that COX-2 and mutated K-ras are connectively associated with the progression of colorectal adenoma [17] .
The aim of this study was to explore the association between K-ras mutation and potential variables known or suspected to be related to the risk of CRC, as dietary habits, smoking status, and folic acid level adjusted for patient characteristics as well as COX-2 promoter polymorphism (À765G > C) as a common genetic abnormality in these patients.
Subjects and methods

Study population
This retrospective cohort study was conducted in Kasr El Aini Hospital on patients attending Tropical Medicine and Gastrointestinal Tract endoscopy Departments and those attending the clinic of the National Cancer Institute, Cairo University during the period extending from April 2009 to March 2010.
The study included 80 patients recently proven to have colorectal cancer by histological examination (56 males and 24 females).
A logistic regression of a binary response variable (Y) on a binary independent variable (X) with a sample size of 80 observations (of which 30% are in the group X = 0 and 70% are in the group X = 1) achieves 80% power at a 0.05000 signifi-cance level to detect a change in Probability (Y = 1) from the baseline value of 0.3-0.561. An adjustment was made since a multiple regression of the independent variable of interest on the other independent variables in the logistic regression obtained an R-Squared of 0.100 [18] .
Written consent was taken from all subjects and approval of the local ethics committee was obtained before this study. All patients were subjected to full history taking with emphasis on the risk factors of interest, namely age, sex, family history of previous CRC, special habits of medical importance (smoking) and dietary history (meat and vegetables consumption using related parts derived from the National Health and Nutrition Examination Survey (NHANES) food frequency questionnaire) [19] . The questionnaire contained several questions regarding dietary intake 1 year ago. For example: ''how often a fruit/vegetable serving was eaten'', ''how often a red meat serving was eaten''. Validity of questionnaire was tested by presenting to other experts in this field of study and was modified when necessary.
The cases were subjected to full clinical examination, abdominopelvic ultrasound, CT, chest X-ray, lower gastrointestinal endoscopy (colonoscopy), laboratory investigations.
Laboratory assessment
Stool samples were taken for testing occult blood. Occult blood was tested by immunochemical assay using monoclonal antibody against human globin, supplied by Acon (ACON Laboratories, Inc. 4108 Sorrento Valley Boulevard San Diego, CA 92121, USA).
Fasting blood samples were withdrawn from each patient (8 ml), divided into 3 aliquots:
Routine chemistry and tumor markers Blood (4ml) was put in plain tube and serum was used for routine chemical investigations (liver enzymes, urea and creatinine) and tumour markers. All routine chemistry analyzers were analyzed on the automated Roche 917 analyzer, by kits supplied by Roche diagnostics (Roche Diagnostics GmbH, D-68298 Mannheim).
Serum CEA was analyzed by solid phase, two-site chemiluminescent enzyme immunometric assay on the Immulite autoanalyzer. The instrument and the kits were supplied by Seimens healthcare diagnostics (1717 Deerfield Road Deerfield, IL 60015-0778, USA).
CA19-9 was assayed in serum samples by electrochemiluminescent assay on Elecsys 1010 system. The instrument and the kits were supplied by Roche Diagnostics. The procedure was done according to the manufacturer's instructions.
Folic acid and hematocrite
Two ml blood was put on EDTA tube for RBC folic acid and hematocrite assay. Folic acid was assayed in blood samples by Competitive Chemiluminescent enzyme immunoassay on the Immulite autoanalyzer. Whole blood folate was assayed first in an hemolysate (1 part EDTA blood + 20 parts freshly prepared 1% ascorbic acid). This value is then converted into RBC folate according to the following equation: Red Cell Folic Acid = whole blood folic acid (corrected for the 21-fold dilution) · (100/haematocrite). The instrument and the kits were supplied by DPC-Seimens [20] .
DNA extraction and genotyping
Genomic DNA was extracted from two ml of venous blood on EDTA using proteinase K digestion followed by a salting out procedure based on the method described by [21] .
Mutations at codons 12 of exon one of the K-ras gene were detected by an enriched semi-nested polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) [22] . The first round amplification was performed using the primer DD5P: 5 0 TCATGAAAATGGTCAGAGAA 3 0 , and to create the restriction site for BstNI [CCTGG] that is lost when a K-ras codon 12 mutation exists, we used the mutant primer K-ras 5 0 : 5 0 ACTGAATATAAACTTGTGGTAGTTGGA CCT 3 0 for 10 cycles (Denaturation at 92°C for 15 s, annealing at 44°C for 15 s and extension at 72°C for 15 s). Amplification was done in Hybaid thermal cycler supplied by Promega (Promega Corporation 2800 Woods Hollow Road Madison, WI 53711, USA).This was followed by Restriction Enzyme Cleavage using the BstN1 restriction enzyme.
The digested product was reamplified using the second round amplification with the previous primer K-ras 5 0 together with K-ras 3 0 primer (5 0 TCAAAGAATGGTCCTGGACC 3 0 ) for 35 cycles (92°C for 15 s , annealing at 54°C for 15 s and extension at 72°C for 15 s). The latter primer artificially introduces an internal control to assure the completion of enzymatic digestion. This was followed by digestion of 5 ll of the amplified product using the BstN1 enzyme.
After agarose gel electrophoresis (4%) using electrophoresis apparatus and ethidium bromide stain (0.5 mg/mL), the point mutation was detected by ultra violet light transillumination. The 143 base pair (bp) band depicts the mutant allele, and the 114-bp band depicts the normal allele, Fig. 1 .
The COX-2 À765G > C genotypes were determined by the PCR-RFLP assay [16] . The target sequence was amplified using the following primers: 5 0 -GGCTGTATATCTGCTCTA-TATGC-3 0 (forward) and 5 0 -CCGCTTCCTTTGTCCAT-CAG-3 0 (reverse). Amplification was performed for 1 min at 94°C followed by 35 cycles of 30 s at 94°C, 30 s at 59°C, and 30 s at 72°C, with a final step at 72°C for 1 min. The PCR products were then digested with Aci1 (New England BioLabs) and separated on agarose gel electrophoresis (4%). After electrophoresis, homozygous C allele was represented by a DNA band sized at 306 bp, whereas homozygous G allele 
Data analysis
Quantitative data were summarized as mean and standard deviation (if normally distributed) and as median and interquartile range (25-75th percentiles) for non-normal data. All variables were first examined by means of univariate analysis to assess the importance of each of them on the K-ras mutation. They were compared by student t-test or by Mann-Whitney test as appropriate. Qualitative data were summarized as percent and compared by chi-square test.
Forward stepwise logistic regression analysis was run to select the minimum combination of variables that maximally discriminates between patients prone to develop K-ras mutation and those who are not. K-ras mutation was used as the (binary) dependent variable; while the initial selection of independent (explanatory) variables in this model was based on clinical experience and medical literature.
A specific model was produced; in addition, the proportion of explained variance R 2 was calculated. For all variables, odds ratio estimates with corresponding 95% Wald CIs are presented.
Logit (P) which is the natural log of the odds of occurrence of K-ras mutation is converted into probability (P) of K-ras mutation either by looking its value in logit table [23] or by using the following equation:
P values >0.5 predict K-ras mutation, while values <0.5 suggest no mutation. The predicted probability of mutation was calculated for the 80 studied CRC patients and was compared against their actual mutation found.
Statistical analysis was run on SPSS for Windows, release.11.0. P values <0.05 were considered statistically significant.
Results
This study was conducted on 80 colorectal cancer patients proven by histopathological examination. Their mean age was 57.03 years with minimum of 20 years and maximum of 75 years of age. The characteristics of the patients under study are shown in Table 1 . The group included 56 (70%) males and 24 (30%) females.
Dietary history revealed the following data: Most of the patients (83.7%) reported red meat consumption at a frequency of 3-7 times/week. Approximately half of the patients reported intake of green leafy vegetables at the same frequency, while intake at a frequency of 1-3 per month was reported by one third of them. Daily consumption of tea and coffee was recorded in 98.75% of the patients. Smoking was present in 49% of the cases, Table 1 .
Results of all laboratory investigations are listed in Table 2 . The K-ras mutation was present in 28.7% of the patients. Cyclooxygenase 2 (COX-2) À765G > C polymorphism revealed GG, n = 50 (62.5%), GC, n = 21 (26.2 %) and CC genotype in 9 cases (11.3 %).
By comparison of the resulting data of the K-ras mutation positive group and the mutation negative group as shown in Table 3 , there was no statistical significant difference regarding age, sex distribution and family history in the two groups. Also, the dietary data showed that mean meat consumption per week and the green leafy vegetables consumption among the mutation positive group did not vary significantly from the negative group. The situation was the same regarding the a All data are frequency (%) except for the age (mean ± SD).
mean tea and coffee consumption per day and smoking. The median laboratory findings also, did not vary significantly between the two groups. However, the red blood cell folic acid level was much lower in the positive group than the negative group and this difference was highly significant statistically, P = 0.002. Folic acid concentration was higher in males (median = 173.5 ng/ml, 95% CI: 86.9-290.5) than in females (median 85 ng/ml, 95% CI: 79.3-116.4), P = 0.002. Other variables did not differ between males and females.
Forward stepwise logistic regression was run to select the minimum combination of variables that maximally discriminates between patients prone to develop K-ras mutation and those who are not, so as to construct a prediction model to help the prediction of those having a higher probability to develop K-ras mutation. K-ras mutation was used as the (binary) dependent variable ; while RBCs folate level, gender, age, smoking, family history of CRC, CEA, CA19-9, consumption of meat and green leafy vegetables, COX-2 genotype were entered as independent (predictor) variables, Table 4 . Only, the RBCs folate (P = 0.0018) followed by gender (P = 0.036) Table 4 showed the predicted probability of mutation when compared against their actual mutation status and it demonstrates that the overall predictive accuracy was 75% (60 out of 80 were correctly diagnosed). Prediction of no mutation was better (48 out of 59; specificity = 84.2%) than prediction of mutation (12 out of 21; sensitivity = 52.17%).
Discussion
In this study K-ras mutation was found in 29% of the 80 patients suffering from colorectal cancer. We found that RBC folic acid was significantly deficient in CRC patients with K-ras mutations in comparison with CRC patients free of the mutations, suggesting that folic acid may be a risk factor for K-ras mutation development.
Our study aimed at investigating the association between potential variables known or suspected to be related to the risk of colorectal cancer and the occurrence of K-ras mutation thus explaining how such variables play a role in CRC tumorigenesis; whether risky or protective role. Fulfilling this aim would contribute better to our understanding of CRC pathogenesis, elaborate more on the use of K-ras mutation in CRC diagnostic work-up and underscore protective factors that should be recommended and risk factors that might be avoided.
Almost 90% of CRC is diagnosed in people aged 50 years or older [24] and it predominates in males more than in females [25] . This finding is consistent with our results where the mean age of patients with mutation positive was 58 years with males predominant in 78.3%.
A mutated K-ras gene contributes to the transition of an intermediate adenoma to a late adenoma or carcinoma [12, 26, 27] . Our figure (29%) exceeds the figure reported by Naguib et al. study (22%) who recommended further work to identify the molecular background of CRC in UK [28] . Other investigators compared the frequency of K-ras in Egypt with western countries. It was found that K-ras was unusual in Egyptian colorectal cancer patients (11%) vs 28-48% in western patients with colorectal cancer. They explained this by the fact that the pathogenesis of colorectal carcinoma in Egypt has unique features [10] . In addition, a study was done to compare K-ras frequency in the Middle East, Egypt was the lowest 18% vs 33% and 34% in Jordan and Turkish patients with colorectal cancer, respectively [11] .
Recognition of ras mutations may be helpful in screening and early diagnosis of colorectal cancer, as well as it may be a gate for therapeutic potentials [29] . Clinical trials revealed that patients with none mutant K-ras had better clinical response in terms of prolonged median progression-free survival and overall response rates when compared to mutant K-ras [30, 31] .
Frequent red meat intake as a major source of animal fat, was associated with the increased risk of colon cancer [32] [33] [34] . On the other hand, green leafy vegetables are thought to be protective from CRC due to their high fiber content, which in turn has many roles including diluting and binding potential carcinogens [35] . Our patients reported a high frequency of red meat intake, and a low frequency of green leafy vegetables. Frequent daily intake of coffee and tea was also reported by the patients. The caffeine and theophylline found in coffee and tea have been shown to enhance fragile site expression induced by folate restriction. i.e. act synergistically with inadequate folate status to augment this damage, which can enhance carcinogenesis [36, 37] .
The role of folic acid in the expression of proteins involved in proliferation, DNA repair, apoptosis, cytoskeletal organization, and expression of proteins implicated in malignant transformation has been studied [38] . It seems that the protective effect of folic acid comes from supplements rather than higher dietary intake, and this may be due to its lower bioavailability when in food [39] . However, a great debate is present regarding the association between K-ras mutation and folic acid levels. Many researches demonstrated that the occurrence of CRC depends upon the time and form of folate intake. Some reported a lower incidence of K-ras mutated colon adenomas in individuals with higher folate intake [39] [40] [41] [42] . In contrast, Kim and Luebeck et al. [43, 44] found that folate deficiency has an inhibitory effect whereas folate supplementation has a promoting effect on the progression of established colorectal neoplasms. In addition, the influence of dietary folate nutrient intake on colon cancer risk did not seem to differ with K-ras mutational status in a study conducted by Schernhammer et al. [45] .
Many evidences indicate that significant exposure to cigarette smoking is associated with an elevated risk for CRC and could be a factor of an early onset of CRC. It may be mediated through the upregulation of the expression of VEGF, resulting in the induction of cellular proliferation and angiogenesis [46] . In our analysis, the K-ras mutation was not associated with smoking status. This can be explained by the method of history taking which depended on the questionnaire of patients if positive or negative and not on the smoking index rate.
In the present study, with the exception of the mean red blood cell folic acid level, which was much lower in the mutation positive group than the negative group this difference was highly significant statistically. The other studied variables did not vary significantly between the mutation positive and nega- tive groups. The current study unequivocally demonstrated the effect of sex and folic acid on K-ras mutation. Not only did it study the variables qualitatively, but also it measured their effects quantitatively. When the association between sex and gene mutation was evaluated by univariate analysis, it was non-significant. The effect of sex was masked by significantly higher folate levels in males than females. Should both sexes have similar folate levels, sex would stand out as a risk factor. Masking of gender by the underlying folate level was unrevealed when multivariate analysis was conducted. The adjusted odds ratio (OR) for RBC folic acid was 0.983 when gender was held constant (i.e. among people of the same gender, a person is 0.983 times likely to have K-ras mutation for each 1 ng/ml higher folate).
The adjusted OR for gender was 4.36; thus males were 4.4 times more likely to get K-ras mutation than females when their RBCs folate levels were held constant.
The risk of development of K-ras mutation among CRChigh-risk population could be quantified using the prediction equation, so as to select those who require close monitoring for the development of CRC. The degree of risk of mutation can be anticipated, in a dose-dependent manner to folic acid level deficiency. For a unit (1 ng/ml) lower folate is attended with 1.02 risk increase, and 1.22 times more likely to get Kras mutation for 10 ng/ml lower folate level and 7.2 times more risky for 100 ng/ml lower folate level.
Failure to incriminate folate level in K-ras mutation by some researchers [45] might be attributed to masking of its effect by other factors working in opposite direction. Segregation of the effect of each variable, while holding others constant, might underscore the significant variables; a policy that was followed in the current study.
COX-2 has been shown to play an important role in carcinogenesis in various organ systems including colon and it was closely correlated to the prognosis of patients [47] . Both COX-2 and K-ras produced synergistic effect in the development of colorectal cancer [48] . However, in our study there was no association between COX-2 genotypes and K-ras mutation. This may be attributed to our study on the genotypes in peripheral blood and not their expression in cancer tissues.
In conclusion, this study demonstrated that there is a potential link between RBC folic acid and k-ras mutation suggesting that folic acid may be a risk factor for K-ras mutation development.
It is recommended to use the prediction model in screening for K-ras mutation. Patients with a high calculated risk should undergo genotyping for the K-ras genotype and should be closely monitored (e.g. radiologically, endoscopically) for early detection of any cancerous or pre-cancerous lesions. Also, nutritional education about decreasing consumption of red meat and increase consumption of green leafy vegetables with emphasis on folate-dense fruits & vegetables. Many more cases should be studied, however, before any firm conclusions can be drawn.
